Final analysis of the phase 1 trial of NY-ESO-1-specific T-cell receptor (TCR) T-cell therapy (letetresgene autoleucel; GSK3377794) in patients with advanced synovial sarcoma (SS) Meeting Abstract
| Authors: | D'Angelo, S.; Demetri, G.; Van Tine, B.; Druta, M.; Glod, J.; Chow, W.; Pandya, N.; Hasan, A.; Chiou, V.; Tress, J.; Edwards, J.; Young, T.; Woessner, M.; Gyuerdieva, A.; Zajic, S.; Goodison, S.; Araujo, D. |
| Abstract Title: | Final analysis of the phase 1 trial of NY-ESO-1-specific T-cell receptor (TCR) T-cell therapy (letetresgene autoleucel; GSK3377794) in patients with advanced synovial sarcoma (SS) |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A182 |
| End Page: | A183 |
| Language: | English |
| ACCESSION: | WOS:000616665300290 |
| DOI: | 10.1136/jitc-2020-SITC2020.0298 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 298 -- Source: Wos |
